Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study.

A Veronesi; M D Magri; U Tirelli; A Carbone; F Mazza; S Franceschi; R Talamini; A Ardizzoni; L Canobbio; R Rosso

doi:10.1097/00000421-198810000-00012

Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study.

Identifier:nobleid.org/w1/20260515/CC50CD65

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CC50CD65.svg?ark=w1%2F20260515%2FCC50CD65)](https://nobleid.org/work/w1/20260515/CC50CD65)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study.

Identifier:nobleid.org/w1/20260515/CC50CD65

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CC50CD65.svg?ark=w1%2F20260515%2FCC50CD65)](https://nobleid.org/work/w1/20260515/CC50CD65)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work